A prospective, observational study of deferasirox in patients with myelodysplastic syndrome
Latest Information Update: 19 Jan 2017
At a glance
- Drugs Deferasirox (Primary)
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- Acronyms Rythmex
- 19 Jan 2017 New trial record
- 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology